Anika Therapeutics Inc.
ANIK
Market Cap$409.12M
Close$
$21.81
20.9% downside
Current Fair Value
20.9% downsideOvervalued by 20.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $409.12 Million |
|---|---|
| Enterprise Value | $336.25 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-5.64 |
| Beta | 0.63 |
| Outstanding Shares | 14,828,456 |
| Avg 30 Day Volume | 48,427 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.95 |
|---|---|
| PEG | -0.42 |
| Price to Sales | 2.51 |
| Price to Book Ratio | 1.97 |
| Enterprise Value to Revenue | 2.02 |
| Enterprise Value to EBIT | -13.21 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Anika Therapeutics Inc.
CEO: Joseph Darling